Arax Advisory Partners’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100K Buy
4,416
+3,849
+679% +$88.1K ﹤0.01% 2730
2026
Q1
$13.2K Sell
567
-43
-7% -$926 ﹤0.01% 2305
2025
Q4
$12.2K Sell
610
-2,163
-78% -$42.2K ﹤0.01% 2365
2025
Q3
$50.6K Buy
2,773
+2,607
+1,570% +$50.8K ﹤0.01% 1832
2025
Q2
$3.33K Buy
166
+155
+1,409% +$2.98K ﹤0.01% 2384
2025
Q1
$200 Sell
11
-493
-98% -$8.84K ﹤0.01% 2597
2024
Q4
$8.74K Buy
504
+11
+2% +$211 ﹤0.01% 1534
2024
Q3
$9.52K Hold
493
﹤0.01% 1441
2024
Q2
$8.09K Buy
+493
New +$7.65K ﹤0.01% 1374

Other funds holding INVA

Arax Advisory Partners's INVA Position: Q2 2026 in Review

Arax Advisory Partners increased its Innoviva (INVA) stake by 679% in Q2 2026, buying an estimated $88.1K and bringing the position to 4,416 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #2730.

Arax Advisory Partners first reported a position in INVA in Q2 2024 and has held it in 9 quarters since. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Arax Advisory Partners held 4,416 shares of Innoviva worth $100K as of Q2 2026.
  • Arax Advisory Partners bought 3,849 Innoviva shares in Q2 2026, an estimated $88.1K.
  • Innoviva made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2730 holding.
  • Arax Advisory Partners first reported a position in Innoviva in Q2 2024 and has held it in 9 quarters since.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.